Abstract 1569: Dual action tumor immune agonist (DATIA) ADCs activating STING pathway and subsequently inducing cytotoxicity of tumor cells exhibits potent and lasting in vivo tumor growth inhibition in multiple preclinical tumor antigen positive cancer models